TG Therapeutics, Inc. (TGTX) NASDAQ
46.59
+3.22(+7.42%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 4.3B |
| Enterprise Value | 4.48B |
| P/E Ratio | 14.66 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 10.25 |
| Price/Book Ratio | 11.61 |
| Enterprise/Revenue | 10.69 |
| Enterprise/EBITDA | 47.74 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.66 |
| Operating Margin | 0.21 |
Management Effectiveness
| Return On Assets | 0.3 |
| Return On Equity | 0.87 |
Income Statement
| Revenue | 616.29M |
| Revenue/Share | 4.85 |
| Gross Profit | 515.57M |
| EBITDA | 134.36M |
| Net Income | 447.18M |
| Diluted EPS | 2.77 |
Balance Sheet
| Total Cash | 514.43M |
| Total Cash/Share | 3.56 |
| Total Debt | 753.56M |
| Total Debt/Equity | 1.29 |
| Current Ratio | 5.81 |
| Book Value Per Share | 4.04 |
Price History
| 52-Week Change | 18.92 |
| 52-Week High | 49.31 |
| 52-Week Low | 25.28 |
| Moving Average 50 Days | 37.17 |
| Moving Average 200 Days | 32.84 |
Statistics
| Average Volume | 2.09M |
| Shares Outstanding | 153.08M |
| % Held by Institutions | 73.02 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 4:225 |
| Last Split Date | April 30, 2012 |
